Search for: "AUTO CREDIT INC v LONG" Results 61 - 79 of 79
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Nov 2008, 1:36 pm
You can separately subscribe to the IP Think Tank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: USPTO releases ‘FY2008 Performance and Accountability Report’; claims success despite backlog (Managing Intellectual Property) (Law360) (Patent Librarian’s Notebook) (Patent Docs) (Peter Zura's 271 Patent Blog) (Patent Prospector) USPTO transition team appointed (Managing Intellectual Property) (Intellectual Property… [read post]
16 May 2008, 8:03 am
: (GenericsWeb), Europe: New EBA referral T 1319/04 regarding patentability of known medicament for new treatment of same illness: (IPKat), Europe: Patentability of biotechnology in Europe: (IAM), Europe: New EPO Enlarged Board case referrals: T1319/04 Dosage Regimen, T1242/06 Essential Biological Process: (Hal Wegner), Thailand: Compulsory licensing: Affordable health for Thailand thanks to Matrix Labs: (Spicy IP), Thailand: European Parliament set to reprimand Mandelson for… [read post]
25 May 2022, 9:01 pm by Richard Zelichov and Trevor T. Garmey
Securities Litigation, 768 F.3d 1046 (9th Cir. 2014) (violations of Section 303 do not give rise to private right of action under Section 10(b) and Rule 10b-5) with Stratte-McClure v. [read post]
5 Jun 2009, 3:25 pm
The fact that this is an electronic publication permits the user to locate information in the database by using key words and phrases.You may order your copy of The Section 207-a/c Case Book by sending your name, the name of your organization, your mailing address and telephone number, purchase order number, confirmation of your tax exempt status, if appropriate, and your e-mail address to:Publications@nycap.rr.comor you may mail your organization's purchase order form to:Public Employment Law… [read post]
18 Jan 2011, 1:44 pm by WIMS
For instance, the FDA has long considered saccharin, the artificial sweetener, safe for people to consume. [read post]
5 Feb 2021, 1:25 am by Shannon O'Hare
If so, is it necessary to consider that entity’s regulatory status, or reassess KYC/AML and credit risk? [read post]
25 Mar 2010, 1:47 pm by Bexis
  Only if we've got a really powerful defense, like preemption in In re Medtronic, Inc. [read post]
4 Nov 2013, 9:46 am by Jane Chong
 But legal academics have spent thirty years disagreeing with that proposition and dreaming up liability schemes designed to force software vendors to shoulder some of the costs long borne entirely by users. [read post]
26 Sep 2017, 6:41 am by Dan Carvajal
The factors which led states to abandon gross receipts taxes have not changed; they remain an inefficient and inequitable form of taxation long since superseded by more modern revenue tools. [read post]